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Abstract: Degradable and injectable hydrogels may be
ideal for bone-tissue engineering, especially in the craniofa-
cial region because of the ease of access for injection. Algi-
nate hydrogels potentially could be used as injectable cell
delivery vehicles, but they exhibit a limited range of me-
chanical properties and uncontrollable disintegration time.
Therefore we synthesized new hydrogels, composed of
poly(aldehyde guluronate) (PAG) and adipic acid dihydra-
zide, that have a wide range of mechanical stiffness and
controllable degradation rate. MC3T3-E1 cells adhered and
multiplied on PAG hydrogels in vitro. When primary rat
calvarial osteoblasts were mixed with PAG hydrogels and
subcutaneously injected into the backs of mice, mineralized
bone tissues were formed 9 weeks following implantation.
These hydrogels may find wide utility as an injectable de-
livery system for bone precursor cells as well as for other
applications in tissue engineering. © 2001 John Wiley &
Sons, Inc. J Biomed Mater Res 56: 228–233, 2001
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INTRODUCTION
Tissue engineering is a recently developed field that
aims to replace lost tissue or whole organ function.1,2
Tissues or organs can be engineered with many dif-
ferent strategies. A particularly attractive approach
utilizes a combination of a patient’s own cells and a
polymeric construct. In this approach, tissue-specific
cells are isolated from a small tissue biopsy and ex-
panded in vitro. The cells subsequently are placed onto
a polymeric construct that acts as a synthetic extracel-
lular matrix. The cell–polymer construct delivers the
cells to the desired site in the body, offers a space for
tissue regeneration, and potentially controls the struc-
ture and function of the engineered tissue.3,4
There have been many demands for reconstructing
bone defects, especially in the craniofacial region as a
result of congenital defects, trauma from accidents,
and disease. It would be ideal to access these sites
using minimally invasive techniques that would leave
minimal scarring and would minimize patient dis-
comfort. Tissue engineering utilizing hydrogels may
offer an attractive approach for bone regeneration and
integration with the host tissue in the craniofacial re-
gion. Hydrogels already have found numerous appli-
cations in drug delivery5–8 and generally are consid-
ered biocompatible as they have structural similarity
to the macromolecular-based components in the
body.9 They have been used in cell transplantation
because they can be injected into the body in a mini-
mally invasive manner for tissue engineering applica-
tions.10–12 This delivery form for a cell–polymer con-
struct may lessen a patient’s trauma, pain, and the cost
of a procedure.13
Alginate has been widely utilized in various bio-
medical applications due to its easy gelation, biocom-
patibility, and low toxicity.14,15 Alginate forms hydro-
gels via ionic crosslinking with divalent cations. How-
ever, ionically crosslinked hydrogels have a limited
range of mechanical properties and disintegration be-
havior. Therefore, by covalent crosslinking, we re-
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cently synthesized new hydrogels composed of algi-
nate derivatives.16 These covalently crosslinked hy-
drogels had a wide range of mechanical stiffness and
a degradation rate dependant on the controllable
crosslinking density,17 both of which are useful for
drug-delivery applications.8 In this paper we describe
degradable and injectable hydrogels prepared from
poly(aldehyde guluronate) (PAG) and their initial use
in bone-tissue engineering. PAG was obtained from
alginate by acid hydrolysis followed by oxidation, and
it easily formed hydrogels with adipic acid dihydra-
zide as a covalent crosslinking molecule. PAG hydro-
gels showed degradation rates ranging from a few
days to several weeks, depending on the crosslinking
density, and they were found to be useful for bone-
tissue engineering.
MATERIALS AND METHODS
Preparation of PAG and hydrogel formation
Polyguluronate (PG) initially was isolated from sodium
alginate (Protanal LF 20/60, Pronova Co., Norway) by acid
hydrolysis and collected at pH 2.85.17,18 The precipitate was
re-dissolved in double-distilled water at neutral pH, and
activated carbon was added for further purification. The so-
lution was stirred thoroughly for 30 min, filtered to remove
the activated carbon, precipitated by ethanol, and lyophi-
lized (weight-average molecular weight, Mw = 7000; poly-
dispersity index, Mw/Mn = 1.60). PG then was oxidized with
0.25M of sodium periodate solution (Aldrich, Wisconsin) at
room temperature. The ratio between the guluronate unit
and the periodate was 1:1. An equimolar amount of ethylene
glycol was added after 19 h to stop the oxidation reaction.
The resultant solution was filtered, dialyzed (molecular
weight cut-off, 1000, Spectra/Port) for 3 days, and lyophi-
lized (Mw = 5700, Mw/Mn = 1.64).
17 The degree of oxidation
of PAG was determined to be 66.5%, from a trinitrobenzene
sulfonic acid (TNBS) assay.17
A 20 wt % solution of poly(aldehyde guluronate) (PAG)
was mixed with different amounts of adipic acid dihydra-
zide (Aldrich, Wisconsin) for in vitro characterization stud-
ies, placed into 48-well tissue culture plates, and incubated
at room temperature for 4 h to form hydrogels. All the so-
lutions were prepared in Dulbecco’s modified Eagle’s me-
dium (DMEM; Gibco BRL, Gaithersburg, Maryland), and
pH was adjusted to 7.4 before mixing. The final concentra-
tion of PAG in the hydrogel before swelling was 6 wt %, and
AAD concentration varied from 100 to 200 mM. All the hy-
drogels were immersed in DMEM (pH 7.4) at 37°C for 24 h
to reach complete hydration.
Characterization of PAG hydrogels
The coupling reaction between aldehyde and hydrazide
groups was confirmed by disappearance of a symmetric vi-
brational band of the aldehyde group at 1735 cm−1 and ap-
pearance of a carbonyl band of the hydrazide at 1658 cm−1
from the FT-IR spectra, as previously reported.17 PAG hy-
drogels (11 mm in diameter and 3 mm thick) were prepared
(n = 4), and their elastic moduli were measured from a com-
pression test using a mechanical tester (MTS Bionix 100,
MTS Systems, France). The deformation rate was 0.5 mm/
min, and the diameter of the indenter was 3.15 mm. To
determine gel swelling, the hydrogels were swollen in
DMEM (pH 7.4) for 24 h at 37°C, excess water on the hy-
drogels was removed, and the gels were weighed. The swell-
ing ratio (Q) was defined as the mass ratio of absorbed water
and the dried gel.
Degradation of PAG hydrogels
Thirty-two disks of PAG hydrogels crosslinked with dif-
ferent amounts of AAD were prepared, immersed in DMEM
(pH 7.4), and incubated at 37°C under 5% CO2 atmosphere
for varying times. The dry weight of four samples was ana-
lyzed at each time point by removing the samples from the
DMEM and drying them in a lyophilizer. All the experi-
ments were done under sterile conditions to prevent bacte-
rial and fungal contamination. Statistical analysis was car-
ried out using Instat software, and a Student’s t test was
performed to compare samples at different time points or
conditions.
In vitro cell adhesion
MC3T3-E1 mouse calvarial preosteoblasts, a generous gift
from Dr. M. Kumegawa (Josai Dental University, Japan),
were used to perform cell adhesion experiments on PAG
hydrogels. The MC3T3 cells were cultured in a-Minimum
Essential Media (a-MEM; Hyclone, Logan, Utah) containing
10% fetal calf serum (Hyclone) and 100 units/mL of peni-
cillin–streptomycin (Gibco BRL). PAG hydrogels with 150
mM of AAD were placed in 24-well plates and pretreated
with 0.5 mL of serum-containing media. MC3T3 cells were
seeded on the gels at a density of 10 × 103 cells/cm2. The
medium was changed every other day and photographs
were taken at ×200 magnification 24 h and 5 days following
seeding. The cells were rinsed with phosphate-buffered sa-
line solution before the photographs were taken, and cells at
the 5-day time point were stained with 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to im-
prove cell visibility.
In vivo animal study
PAG hydrogels with 100 or 200 mM of AAD were pre-
pared in a 1-mL plastic syringe and kept at 4°C during cell
isolation. Primary rat calvarial osteoblasts were harvested
using a modified method reported by Pockwinse et al.19
Briefly, cells were obtained from newborn (fewer than 3
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days old) Lewis rat pups (Harlan Sprague–Dawley, India-
napolis, Indiana). The pups were doused with 95% ethanol,
decapitated, and the calvaria were isolated. The calvaria
were stored in Hanks’ balanced salt solution (HBSS; Gibco
BRL) until the isolation was completed. Upon completion of
the harvest, the calvaria were rinsed three times with HBSS
and once with serum-free a-MEM with 100 units/mL of
penicillin–streptomycin and 50 mg/L of gentamicin (Gibco
BRL). Digestion media, which consisted of 2 mg/mL of col-
lagenase P (Boehringer–Mannheim, Indianapolis, Indiana)
and 0.25% trypsin (Gibco BRL) in serum-free a-MEM, was
added at approximately 2 times the volume of the calvaria.
The tubes were capped and placed in a 37°C water bath with
gentle shaking for 20 min. The medium was removed, new
digestion medium was added, and digestion was allowed
for 40 min. The medium again was removed, new digestion
medium was added, and digestion was allowed for 90 min.
After this final digestion, the cells were resuspended in
a-MEM with 10% fetal calf serum. The cells subsequently
were spun down and the supernatant removed. Cells were
mixed with PAG hydrogels using two syringes and a female
connector to achieve a cell concentration of 40 × 106 cells/
mL. Two hundred mL of PAG hydrogel/cell construct were
injected subcutaneously into the backs of 4–5-week-old
SCID mice (Taconic Farms Inc., Germantown, New York).
Hydrogels without cells were used as a control. The mice
were sacrificed after 9 weeks, fixed in formalin, embedded
in paraffin, sectioned, and stained using standard hematoxy-
lin and eosin or von Kossa protocols for microscopic obser-
vation (n = 2). NIH guidelines for the care and use of labo-
ratory animals (NIH Publication £85-23 Rev 1985) were ob-
served.
RESULTS
PAG was prepared from alginate by acid hydrolysis
and oxidation, and formed hydrogels in the presence
of AAD as a covalent crosslinking molecule (Fig. 1).
PAG hydrogels were prepared with different amounts
of AAD to make gels with different degradation rates.
The elastic moduli of the hydrogels crosslinked with
100 and 200 mM of AAD were 18.3 ± 1.4 and 4.3 ± 0.6
kPa, respectively, as measured by compression test-
ing. The swelling ratio (Q) of the hydrogels
crosslinked with 100 and 200 mM of AAD in DMEM
(pH 7.4, 37°C) were 13.2 ± 0.3 and 16.0 ± 0.6, respec-
tively (Fig. 2). Degradation of PAG hydrogels was
monitored by the weight loss of gels in the media over
time. Hydrogels crosslinked with 100 mM of AAD
were completely degraded after 5 days. However, no
statistically significant weight loss of hydrogels
crosslinked with 200 mM of AAD was observed even
after 4 weeks (17 ± 9% loss of initial weight), irrespec-
tive of their initially low modulus and high swelling
ratio (Fig. 3). This will be discussed more fully later.
Cell culture and transplant experiments with bone
precursor cells on PAG hydrogels were carried out to
investigate the cellular interaction of osteoblasts with
PAG hydrogels. MC3T3 cells spread extensively on
the surface of PAG hydrogels within 24 h following
cell seeding, and they proliferated to reach confluency
after 5 days (Fig. 4). PAG hydrogels were mixed with
rat calvarial-derived osteoblasts and subcutaneously
injected into the dorsal region of mice to determine if
bone tissue could be formed with these polymers. No
bone formation was observed for cells injected with
PAG hydrogels crosslinked with 100 mM of AAD,
perhaps due to the rapid degradation of hydrogels
(Fig. 3). However, osteoblasts injected with PAG hy-
drogels crosslinked with 200 mM of AAD formed
bone tissues after 9 weeks (Fig. 5). The bone tissue
formed was present throughout the entire implant but
was clearly most prominent in the outer one-third of
the implantation site. This result likely is due to the
initial lack of vascularization within the implant fol-
lowing injection. The engineered bone tissues were
substantially mineralized, as confirmed by selective
Figure 1. Chemical structure of poly(aldehyde guluronate)
hydrogels crosslinked with adipic acid dihydrazide.
Figure 2. Elastic modulus (E) and swelling ratio (Q) of
PAG hydrogels crosslinked with 100 and 200 mM of AAD.
Hydrogels were swollen in DMEM (pH 7.4, 37°C) for 24 h
before measurement (n = 4).
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staining using the von Kossa reagent [Fig. 5(c)]. No
bone tissue was observed in control hydrogels injected
without osteoblasts even though they showed the
same degradation behavior compared to those in-
jected with cells (data not shown).
DISCUSSION AND CONCLUSIONS
Degradable and injectable hydrogels for tissue en-
gineering applications successfully were prepared
from poly(aldehyde guluronate) by covalent
crosslinking. Osteoblasts readily adhered to PAG hy-
drogels in vitro and formed mineralized bone tissue in
the dorsal region of mice when transplanted on spe-
cific PAG hydrogels. This study may provide a first
step in the development of these degradable and in-
jectable hydrogels for bone-tissue engineering.
There are many candidate hydrogels that could be
utilized as a degradable and injectable cell transplan-
tation vehicle. However, there have been few reports
on bone-tissue engineering utilizing injectables. Re-
ports to date have utilized poly(propylene fumarate)/
b-tricalcium phosphate composites20 and photopoly-
merizable polyanyhydrides,21 likely due to their os-
teoconductive properties. We previously reported the
synthesis and characteristics of PAG hydrogels de-
rived from alginate.16,17 PAG can be prepared by a
simple method and readily form gels by reaction with
bifunctional crosslinking molecules. Aldehyde groups
in PAG are very reactive toward hydrazide groups of
AAD compared to carboxyl groups, and thus PAG
reacts with AAD rapidly without any catalyst. The
resultant hydrazone bonds are labile to hydrolysis
even at neutral pH, and this makes PAG hydrogels
degradable in a controllable manner, depending on
the crosslinking density. For bone-tissue engineering,
polymeric constructs should degrade in a controlled
manner to allow the bone-remodeling process.22
Therefore PAG hydrogels were considered to be suit-
able for this application due to their controllable deg-
radation rate over time as well as to their biocompat-
ibility. These gels would not be suitable for the regen-
eration of bones for load-bearing applications due to
the requirement of high moduli (e.g., ∼100 MPa for the
trabecular bone in the human mandible and ∼20 GPa
for the human cortical bone)23,24 unless fixation also
was provided.
One interesting feature of these PAG hydrogels is
Figure 3. Weight loss of PAG hydrogels crosslinked with
100 and 200 mM of AAD during degradation. Hydrogels
were immersed in DMEM (pH 7.4, 37°C) under 5% CO2
during degradation. n.s. indicates no statistical difference in
mass between any of the time points for these gels (n = 4).
Figure 4. Photomicrographs of MC3TC cells adhered to the
surface of PAG hydrogels crosslinked with 150 mM of AAD
after (a) 24 h and (b) 5 days of culture. Original magnifica-
tion ×200. [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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that mechanical properties and degradation time can
be decoupled.17 Those two properties generally are
coupled to each other as both typically rise and fall
together with the crosslinking density of the gels. For
example, PAG hydrogels crosslinked with 100 mM of
AAD showed coupled mechanical stiffness and deg-
radation rate, which means that both features were
proportional to each other. However, PAG hydrogels
crosslinked with 200 mM of AAD decoupled the ri-
gidity and the degradation rate. Although PAG hy-
drogels crosslinked with 200 mM of AAD showed sig-
nificantly less modulus than those crosslinked with
100 mM of AAD (p < 0.05), no statistically significant
degradation of the gels was observed over 4 weeks
(Figs. 2 and 3). We previously have demonstrated that
hydrogels synthesized with excess amounts of
crosslinking molecules contain significant network de-
fects in terms of dangling single-end molecules, result-
ing in low moduli of gels.17 However, this large num-
ber of dangling single-end molecules allows a re-
crosslinking reaction of the PAG strand following
hydrolysis of the initial crosslinking sites. Therefore,
hydrogels with many dangling single-end molecules
may have no significant change in net crosslinking
density over time and will very slowly degrade. We
previously have shown that PAG hydrogels cross-
linked with 200 mM of AAD contain a high number of
dangling single-end molecules compared to other
gels. It therefore is not surprising that these hydrogels
exhibited a retarded degradation, irrespective of their
low initial modulus and high swelling ratio (Figs. 2
and 3).
A clear challenge for this approach—for any ap-
proach—to engineering large bone defects is adequate
vascular invasion from the host tissue. This is evident
from our findings that indicate bone formation only in
the exterior portions of the scaffold (Fig. 5). This lim-
ited bone formation is likely a result of mass transport
limitations immediately following cell–polymer injec-
tions.25 Similar findings have been reported in past
studies of bone cell transplantation.26 In the future,
simultaneous delivery of angiogenic agents from the
polymer construct may allow the vascularization pro-
cess to be enhanced.27 Delivery of osteoinductive
agents such as bone morphogenetic protein (BMP),
basic fibroblast growth factor (bFGF), insulin-like
growth factor (IGFs), transforming growth factor-b
(TGF-b), platelet-derived growth factor (PDGF), or
plasmid DNA also potentially may improve this ap-
proach to bone-tissue engineering.28,29
Figure 5. Photomicrographs of representative tissue sec-
tions of osteoblasts transplanted in PAG hydrogels
crosslinked with 200 mM of AAD. Tissue sections were
taken after 9 weeks and stained with (a,b) hematoxylin
and eosin and (c) the von Kossa reagent to highlight min-
eralized tissue. Original magnifications were (a,c) ×100
and (b) ×400. The photomicrographs have labels for re-
maining PAG hydrogel (H), newly formed bone tissue
(B), fibrous tissue (F), and blood vessels (V). [Color figure
can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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